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Background: Food hypersensitivity is commonly suspected, but seldom verified. Patients with 
subjective food hypersensitivity suffer from both intestinal and extraintestinal health complaints. 
Abnormalities of the enterochromaffin cells may play a role in the pathogenesis. The aim of 
this study was to investigate enterochromaffin cell function in patients with subjective food 
hypersensitivity by measuring serum chromogranin A (CgA) and 5-hydroxytryptamine (5-HT, 
serotonin) in gut lavage fluid.
Methods: Sixty-nine patients with subjective food hypersensitivity were examined.   Twenty-three 
patients with inflammatory bowel disease and 35 healthy volunteers were included as comparison 
groups. CgA was measured in serum by enzyme-linked immunosorbent assay. Gut lavage fluid 
was obtained by administering 2 L of polyethylene glycol solution intraduodenally. The first 
clear fluid passed per rectum was collected and 5-HT was analyzed by liquid chromatography 
tandem mass spectrometry.
Results: Serum levels of CgA were significantly lower in patients with subjective food hyper-
sensitivity than in healthy controls (P = 0.04). No differences were found in 5-HT levels in 
gut lavage fluid between patients with subjective food hypersensitivity and the control groups. 
There was no correlation between serum CgA and gut lavage 5-HT.
Conclusion: Decreased blood levels of CgA suggest neuroendocrine alterations in patients with 
subjective food hypersensitivity. However, 5-HT levels in gut lavage fluid were normal.
Keywords: food hypersensitivity, chromogranin A, serotonin, gut lavage fluid, liquid 
chromatography
Introduction
Food hypersensitivity is commonly reported, but often remains unexplained, despite 
extensive medical examinations. Patients with such subjective food hypersensitivity 
attribute a number of somatic health complaints to the ingestion of specific foods, 
most often cow’s milk, wheat products, egg, fruits, and vegetables.2 The abdominal 
symptoms are typically consistent with irritable bowel syndrome.2 Psychological 
disturbances are often associated,3 but do not seem to be major predictors of either 
gastrointestinal or extraintestinal symptom severity.4 Hence, the etiology of subjective 
food hypersensitivity remains obscure.
Alterations of the gastrointestinal enterochromaffin cell population has been 
described in patients with functional gastrointestinal disorders,5,6 and are conceivably 
implicated in the pathogenesis of subjective food hypersensitivity. In a preliminary 
study, we recently observed low serum levels of chromogranin A (CgA) in patients 
with subjective food hypersensitivity.7 CgA is stored and secreted together with amines 
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and peptides from the diffuse neuroendocrine system, and 
serve as a precursor for several peptides with regulatory 
functions.8 Enterochromaffin cells are a major source for 
circulating CgA. In addition, enterochromaffin cells secrete 
5-hydroxytryptamine (5-HT, serotonin), a signaling molecule 
regulating several gut functions, including secretion, motility, 
and sensitivity. Indeed, most of the body’s 5-HT is contained 
within enterochromaffin cells. High systemic levels of 5-HT 
may cause symptoms resembling hypersensitivity reactions 
to food, such as diarrhea,9,10 nausea,11 or flushing and heart 
palpitations.12
5-HT is commonly measured in platelets or in plasma, the 
latter being a poor matrix due to rapid degradation of 5-HT 
into 5-hydroxyindolacetic acid. More than 95% of plasma 
5-HT is present in platelets, and studies assessing platelet 
5-HT content in patients with irritable bowel syndrome are 
somewhat conflicting.13–15 Alterations of 5-HT secretion 
within the gut are not necessarily reflected in the systemic 
circulation, and assessing 5-HT in gut tissue samples is 
often considered to be more accurate. However, the surface 
of the gastrointestinal tract is very large, and biopsies can 
only give information from a small fragment of this huge 
area. Indeed, enterochromaffin cell counts seem to vary a lot 
in different studies.16,17 Our group has developed a method 
for analyzing “whole gut 5-HT”, by analyzing gut lavage 
fluid.18 Enterochromaffin cells release 5-HT mainly from 
granules at the basal border, but studies have shown that 
enterochromaffin cells are bipolar and are able to secrete 
5-HT both basally, into the systemic circulation, and api-
cally, into the gut lumen.19–21 Our method quantifies luminal 
enterochromaffin cell secretion along the entire length of the 
small and large bowel.
The aim of the present study was to explore whether 
patients with subjective food hypersensitivity display abnor-
mal enterochromaffin cell functions. To evaluate this, we 
extended our preliminary observations7 and employed our 
recently developed liquid chromatography tandem mass 
spectrometry (LCMS) method for determination of 5-HT in 
gut lavage fluid.18
Materials and methods
Patients
This study included 69 consecutive patients with subjective 
food hypersensitivity and abdominal complaints (55 females 
and 14 males, mean age 39 years, range 21–83 years). The 
patients went through an extensive medical examination, 
including detailed medical history-taking, physical exami-
nation, and routine laboratory tests, in addition to skin-prick 
tests, measurements of total and food-specific IgE levels in 
serum, and double-blind, placebo-controlled food challenge. 
Gastroenterological investigations included a gastroscopy with 
gastric and duodenal biopsy-taking to exclude   Helicobacter 
pylori infection and celiac disease. Intestinal permeability was 
assessed as previously described,22 and levels of calprotectin 
in gut lavage fluid samples were analyzed to exclude inflam-
matory bowel disease.23 Patients with organic gastrointestinal 
diseases, IgE-mediated food allergies, and pregnant or lac-
tating women were not included. A screening questionnaire 
based on the Rome II criteria24 was applied in all patients for 
the diagnosis of irritable bowel syndrome.
control groups
Twenty-seven patients admitted to the Section of Gastro-
enterology at Haukeland University Hospital because of sus-
pected inflammatory bowel disease were included as a “patient 
control group” (11 females and 16 males, mean age 35 years, 
range 21–65 years). A control group consisting of 35 healthy 
volunteers (24 females and 11 males, mean age 33 years, range 
23–61 years) was also included. The participants in this group 
were mainly employees of National Institute of Nutrition and 
Seafood Research or Haukeland University Hospital and stu-
dents at the University of Bergen. Pregnant or lactating women 
were not included. The study was performed in accordance 
with the Declaration of Helsinki and was approved by the 
Regional Committee for Medical Research Ethics.
Intestinal lavage
The procedure was performed in the morning and all the 
participants were fasting from midnight. The method of 
intestinal lavage has been described previously.22 Briefly, 
2 L of isotonic polyethylene glycol solution (MW 3350, 
Laxabon®, Tika, Sweden) was administered through a 
nasoduodenal feeding tube over a period of 40 minutes, 
using a peristaltic pump (505S/RL; Watson Marlow, 
  Falmouth, UK). Approximately 50 µCi of 51Cr-labeled eth-
ylenediaminetetra-acetic acid (51CrEDTA, Amersham, Little 
Chalfont, UK), was added to the solution to allow estimation 
of intestinal permeability.22 A slightly increased intestinal 
permeability has been reported previously in patients with 
subjective food hypersensitivity25 and this parameter was 
not included as a part of the present report. About one hour 
after the start of the polyethylene glycol infusion, the solu-
tion reached the distal colon and bowel movements started. 
The first clear fluid passed per rectum was collected and 
filtered through gauze, and a 4 mL aliquot was collected on 
tubes containing 0.5 mL of a solution with antiseptic and   International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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antiproteolytic activity prepared by adding 1 mL of 10% 
sodium azide (NaN3) to 50 mL of soybean trypsin inhibitor 
(Sigma, Taufkirchen, Germany). The samples were stored 
at -80°C until analysis.
serotonin analysis
5-HT was analyzed by LCMS as described previously.18 
Briefly, a sample of gut lavage fluid was thawed at room 
temperature and centrifuged. The supernatant was collected 
and filtered using a hydrophilic nylon membrane syringe 
filter, 4 mm diameter and 0.45 µm pore size (Chromacol 
Ltd, Trumbull, CT). Aliquots of 50 µL of the filtered 
supernatants were transferred into tubes containing internal 
standard, which was evaporated to dryness in advance. The 
tubes were vortex-mixed for 1 minute, transferred to an 
autosampler vial and submitted to LCMS/MS analysis. The 
internal standard 5-methoxytryptamine (5-CH3O-HT) was 
purchased from Sigma.
The LCMS system used in this study was an Agilent 
1100 series LC/MSD trap, SL model with an electrospray 
interface, a quaternary pump, degasser, autosampler, 
thermostated column compartment, variable wavelength 
ultraviolet light detector, and 25 µL injection volume. The 
column was a Zorbax Eclipse-C8 RP 150 × 4.6 mm, 5 µm 
(Agilent Technologies, Palo Alto, CA). The solvent system 
operated in gradient mode at 0.2 mL/min and consisted of 
water with formic acid 0.1% v/v and acetonitrile, and ultra-
violet detection at 254 nm. Complete system control, data 
acquisition and processing were done using the ChemSta-
tion for LC/MSD version 4.2 from Agilent. The transitions 
monitored were 177 → 160 m/z for 5-HT and 191 → 174 m/z 
for 5-CH3O-HT.
chromogranin A analysis
Fasting venous blood samples were collected at 8.30 am using 
gel vials with no added anticoagulants. The patients were 
fasting for 10 hours. Serum CgA was measured by enzyme-
linked immunosorbent assay following the manufacturer’s 
instructions (ALPCO Diagnostics, Salem, NH).
statistics
Data were analyzed and displayed using the GraphPad Prism 
statistical software package (v 5.00 for Windows; GraphPad 
Software, San Diego, CA). Log-transformed serotonin levels 
were evaluated by analysis of variance, whereas CgA levels 
were evaluated by using unpaired t-tests. All tests were two-
tailed; P values of less than 5% were considered statistically 
significant.
Results
subjects
Organic gastrointestinal diseases were not demonstrated in 
any of the patients with subjective food hypersensitivity. 
Sixty-four (95%) of the 69 included patients with subjective 
food hypersensitivity had irritable bowel syndrome according 
to Rome II criteria, and all completed the lavage procedure. 
Blood samples for CgA analysis were obtained from 32 of 
the patients. All of the 27 control patients with suspected 
inflammatory bowel disease completed the lavage procedure. 
However, blood samples were not obtained from this group. 
Based on the medical examination, including endoscopy and 
histological assessment of mucosal biopsies, 23 of 27 was 
diagnosed with inflammatory bowel disease, 19 had Crohn’s 
disease, and four had ulcerative colitis. The remaining 
patients (n = 4) were excluded from the study. Thirty-five 
healthy volunteers were included, and blood samples for CgA 
analysis were obtained from all of them. Twenty of the 35 
controls agreed to participate in the lavage procedure.
chromogranin analysis
Serum CgA samples from two of the 32 patients with subjec-
tive food hypersensitivity and one of the 35 healthy controls 
were excluded due to use of proton pump inhibitors, which 
elevate CgA in blood. Serum levels of CgA were significantly 
lower in patients with subjective food hypersensitivity com-
pared with healthy controls (P = 0.04, Figure 1).
serotonin analysis
No significant differences in 5-HT levels were demonstrated 
between patients with subjective food hypersensitivity and 
the control groups. No differences in 5-HT levels were found 
between the two control groups either. In the patient group 
and the healthy volunteer group, two of 69 samples and 
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Figure 1 serum chromogranin A levels in patients with subjective food hypersensitivity 
(n = 30) and healthy controls (n = 34). 
Note: Individual values with means ± standard error are displayed and the P value 
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three of 20 samples, respectively, were nondetectable. The 
5-HT analysis revealed a high degree of variance within all 
three groups. There was a trend towards a higher level of 
5-HT in the inflammatory bowel disease group, albeit not 
statistically significant (Figure 2). There was no correlation 
between serum CgA levels and whole gut lavage 5-HT levels, 
neither in patients (r = 0.00005, not statistically significant) 
nor in controls (r = 0.08, P = not statistically significant, 
Figure 3).
Discussion
Most intestinal enterochromaffin cells are of the “open” type 
with apical cytoplasmic extensions which project into the gut 
lumen and short microvilli,26 where they sense and respond to 
the luminal contents by releasing regulatory compounds like 
5-HT and CgA, both into the circulation and in the intestinal 
lumen. Hyperplasia of enterochromaffin cells together with 
an increase in 5-HT containing granules has been reported in 
several studies of both functional disorders and inflammatory 
diseases of the gut,14,27,28 and 5-HT is supposed to be involved 
in the pathogenesis of various gastrointestinal disorders.29–31 
However, in the present study, gut lavage 5-HT were found to 
be normal in patients with subjective food hypersensitivity. 
Patients with inflammatory bowel disease had slightly higher 
mean levels of 5-HT, but the difference was not significant. 
The high degree of variance in the 5-HT data may be due 
to high individual differences, as well as a consequence of 
the preanalytical sampling procedure. The use of gut lavage 
fluid for analytical purposes is unique. Based on our previous 
experience with the procedure,22,23 the first clear fluid was 
chosen because it was desirable to have as few particles as 
possible to avoid analytical problems, but we acknowledge 
that the time point of sampling was not necessarily the same 
for each participant.
Wang et al demonstrated an interesting immunoendocrine 
axis in the gut, where 5-HT production in enterochromaffin 
cells increases in response to secretory products from CD4+ 
T cells.32 Production and secretion of 5-HT from enterochro-
maffin cells may thus depend on the immunological profile 
of the immune response,33 and there is also evidence that 
mucosal 5-HT modulates the immune response via serotoner-
gic receptors expressed by immune cells.34 Indeed, identifica-
tion of multiple 5-HT receptor subtypes in the gut, especially 
5-HT3 and 5-HT4 receptors, suggests multifaceted actions of 
5-HT, and have led to the development of several therapeutic 
agents for functional gastrointestinal disorders.35
Serum CgA was significantly lower in the patients with 
subjective food hypersensitivity compared with the healthy 
controls, which is consistent with our previous results.7 Sidhu 
et al have reported abnormally elevated levels of serum 
CgA in a small proportion of their patients with diarrhea-
  predominant irritable bowel syndrome.36 However, they 
included no healthy controls, and in many of the patients 
with elevated CgA, the levels declined with time, which the 
authors explain as short-lived enterochromaffin cell hyper-
plasia, as previously reported by Dunlop et al.6 Thus, it would 
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Figure  2  Log-transformed  serotonin  levels  in  gut  lavage  fluid  in  patients  with 
inflammatory bowel disease (n = 23), subjective food hypersensitivity (n = 67) and 
controls (n = 17).
Note: Individual values with median are displayed. No significant differences between 
the three groups were observed.
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Figure  3  relationship  between  serum  chromogranin  A  levels  and  gut  lavage 
5-hydroxytriptamine (5-hT) levels in (A) patients (n = 28) with subjective food 
hypersensitivity and in (B) healthy controls (n = 17). 
Note: Pearsons’ r and P values are indicated.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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be of interest to perform serial measurements of CgA during 
a day, and also for several continuous days, in future studies 
to verify possible fluctuations in circulating CgA levels.
Although CgA is a major enteroendocrine secretion 
  product, little is known about its potential role in gastro-
intestinal pathophysiology. CgA serves as a prohormone 
for shorter peptide fragments with regulatory properties.8 
  Fragments of CgA exert antimicrobial effects and may 
modulate gastrointestinal motility, sensitivity, and bar-
rier function.37,38 The low levels of CgA demonstrated in 
the present study could be a consequence of alterations 
in the gut microbial flora in patients with subjective food 
hypersensitivity.39,40 Intriguingly, Dlugoz et al have recently 
demonstrated Chlamydia trachomatis antigens in enteroen-
docrine cells and macrophages of the small bowel in patients 
with irritable bowel syndrome.41 Although the clinical 
significance is yet unknown, this is an exciting finding that, 
together with the present finding of low serum levels of CgA, 
could imply impairment of enterochromaffin cell function 
in patients with subjective food hypersensitivity and irri-
table bowel syndrome. El-Salhy et al recently demonstrated 
decreased CgA-positive cells in biopsies from patients with 
irritable bowel syndrome.42 Thus, a decrease in numbers 
of CgA secretory cells could be an explanation for the low 
serum CgA found in the present study.
Conclusion
We conclude that measurements of systemic CgA reveal 
significantly lower levels in patients with subjective food 
hypersensitivity than in healthy controls, whereas “whole 
gut 5-HT” levels seem to be normal. Impaired secretion of 
CgA may play a role in functional gastrointestinal disorders, 
and warrants further investigation.
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